EUVIMEDEUVIMED entdecken
Crossref

Resveratrol attenuates Cr(VI)-induced disorders of glycolipid metabolism by regulating HNF1b/GPX1 in mice

Chen Liu, Limin Zhang, Siqi Li, Ruixi Zhou, Wenbo Wu, Yumei Liu, Ming Shu, Wanwei Li, Xiaohong Li

Molecular and Cellular Endocrinology · 2025

DOI: 10.1016/j.mce.2024.112408 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular and Cellular Endocrinology, 2025. Verfasst von Chen Liu und 8 weiteren Autor:innen. Beteiligte Einrichtung: School of Public Health, Shandong Second Medical University, Weifang, 261053, China. Hauptthemen laut MEDLINE: Resveratrol, Chromium, Glycolipids, Mice, Inbred C57BL. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 47 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Epidemiological studies have indicated that exposure to hexavalent chromium (Cr(VI)) is associated with increased morbidity in the population. Resveratrol (Res) is a polyphenolic compound known for its role in mitigating oxidative stress and inflammation. In this study, we investigated the effects of resveratrol on Cr(VI)-induced disorders of glycolipid metabolism and elucidated its mechanisms. Male C57BL/6 mice were exposed to resveratrol and Cr(VI) for 45 days. Cr(VI) exposure led to elevated blood glucose levels, impaired glucose tolerance and insulin resistance, oxidative and inflammatory responses, and alterations in glycolipid metabolism molecules such as PCK1 and SREBP1, along with inhibition of HNF1b and GPX1. Resveratrol pretreatment increased the expression of HNF1b and GPX1, reduced oxidative and inflammatory responses, and ultimately ameliorated Cr(VI)-induced glycolipid metabolism disorders. These findings suggest potential new targets for the prevention and treatment of dysglycolipidosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ResveratrolChromiumGlycolipidsMice, Inbred C57BLGlutathione PeroxidaseAnimalsMaleInsulin ResistanceOxidative StressMiceBlood GlucoseLipid Metabolism

Stichwörter der Autor:innen

Glutathione peroxidase 1Glycolipid metabolic disorderHepatocyte nuclear factor 1bHexavalent chromiumResveratrol

Substanzen

ResveratrolChromiumGlycolipidsGlutathione Peroxidasechromium hexavalent ionBlood Glucose

Autor:innen und Institutionen

  • School of Public Health, Shandong Second Medical University, Weifang, 261053, China.
  • Weifang Key Laboratory of Health Inspection and Quarantine, Weifang, 261053, China.
  • School of Public Health, Shandong Second Medical University, Weifang, 261053, China. Electronic address: wanweili@sdsmu.edu.cn.
  • School of Public Health, Shandong Second Medical University, Weifang, 261053, China. Electronic address: lixiaohong66@sdsmu.edu.cn.

Zitieren

APA

Liu, C., Zhang, L., Li, S., Zhou, R., Wu, W., Liu, Y., Shu, M., Li, W., & Li, X. (2025). Resveratrol attenuates Cr(VI)-induced disorders of glycolipid metabolism by regulating HNF1b/GPX1 in mice. Molecular and Cellular Endocrinology. https://doi.org/10.1016/j.mce.2024.112408

Vancouver

Liu C, Zhang L, Li S, Zhou R, Wu W, Liu Y, et al. Resveratrol attenuates Cr(VI)-induced disorders of glycolipid metabolism by regulating HNF1b/GPX1 in mice. Molecular and Cellular Endocrinology. 2025. doi:10.1016/j.mce.2024.112408

BibTeX
@article{Liu2025,
  author = {Liu, Chen and Zhang, Limin and Li, Siqi and Zhou, Ruixi and Wu, Wenbo and Liu, Yumei and Shu, Ming and Li, Wanwei and Li, Xiaohong},
  title = {Resveratrol attenuates Cr(VI)-induced disorders of glycolipid metabolism by regulating HNF1b/GPX1 in mice},
  journal = {Molecular and Cellular Endocrinology},
  year = {2025},
  doi = {10.1016/j.mce.2024.112408}
}
Kostenlos starten →